US4988815A
(en)
*
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
CA2093132C
(en)
*
|
1990-10-05 |
2002-02-26 |
John F. Gerster |
Process for the preparation of imidazo[4,5-c]quinolin-4-amines
|
US5175296A
(en)
*
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
US5389640A
(en)
*
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5268376A
(en)
*
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US6608201B2
(en)
*
|
1992-08-28 |
2003-08-19 |
3M Innovative Properties Company |
Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5395937A
(en)
*
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
US5622965A
(en)
*
|
1993-03-12 |
1997-04-22 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon |
4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists
|
US5352784A
(en)
*
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
KR100341341B1
(ko)
*
|
1993-07-15 |
2002-11-25 |
미네소타 마이닝 앤드 매뉴팩춰링 캄파니 |
이미다조[4,5-c]피리딘-4-아민
|
US5648516A
(en)
*
|
1994-07-20 |
1997-07-15 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
US5644063A
(en)
*
|
1994-09-08 |
1997-07-01 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]pyridin-4-amine intermediates
|
US5741908A
(en)
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
US5693811A
(en)
*
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
JP4101302B2
(ja)
*
|
1997-01-09 |
2008-06-18 |
テルモ株式会社 |
新規アミド誘導体および合成中間体
|
UA67760C2
(uk)
*
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
JP2000119271A
(ja)
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
1h―イミダゾピリジン誘導体
|
US20020058674A1
(en)
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
SK287112B6
(sk)
|
1999-01-08 |
2009-12-07 |
3M Innovative Properties Company |
Použitie zlúčeniny modifikujúcej imunitnú odpoveď pri liečení cervikálnej dysplázie
|
US6486168B1
(en)
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
US6558951B1
(en)
*
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
US6541485B1
(en)
|
1999-06-10 |
2003-04-01 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6573273B1
(en)
|
1999-06-10 |
2003-06-03 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6756382B2
(en)
*
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6331539B1
(en)
*
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6916925B1
(en)
|
1999-11-05 |
2005-07-12 |
3M Innovative Properties Co. |
Dye labeled imidazoquinoline compounds
|
US6376669B1
(en)
|
1999-11-05 |
2002-04-23 |
3M Innovative Properties Company |
Dye labeled imidazoquinoline compounds
|
JP3436512B2
(ja)
*
|
1999-12-28 |
2003-08-11 |
株式会社デンソー |
アクセル装置
|
KR20020073211A
(ko)
*
|
2000-02-09 |
2002-09-19 |
호쿠리쿠 세이야쿠 가부시키가이샤 |
1 에이치-이미다조피리딘유도체
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6677347B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6664264B2
(en)
*
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6660747B2
(en)
*
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
JP2008531580A
(ja)
*
|
2000-12-08 |
2008-08-14 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答修飾因子の標的化送達のための組成物および方法
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
US6677348B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6545017B1
(en)
*
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6667312B2
(en)
*
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US7226928B2
(en)
*
|
2001-06-15 |
2007-06-05 |
3M Innovative Properties Company |
Methods for the treatment of periodontal disease
|
JP2005501550A
(ja)
*
|
2001-08-30 |
2005-01-20 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫反応調整剤分子を用いた形質細胞様樹状細胞を成熟させる方法
|
DK1719511T3
(da)
*
|
2001-11-16 |
2009-04-14 |
Coley Pharm Group Inc |
N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methansulfonamid, en farmaceutisk sammensætning omfattende samme, og anvendelse deraf
|
AU2002363954B2
(en)
*
|
2001-11-29 |
2008-04-03 |
3M Innovative Properties Company |
Pharmaceutical formulations comprising an immune response modifier
|
CA2365732A1
(en)
*
|
2001-12-20 |
2003-06-20 |
Ibm Canada Limited-Ibm Canada Limitee |
Testing measurements
|
US6677349B1
(en)
*
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
WO2003072026A2
(en)
*
|
2002-02-22 |
2003-09-04 |
3M Innovative Properties Company |
Method of reducing and treating uvb-induced immunosuppression
|
AU2003233519A1
(en)
|
2002-05-29 |
2003-12-19 |
3M Innovative Properties Company |
Process for imidazo(4,5-c)pyridin-4-amines
|
BR0311648A
(pt)
*
|
2002-06-07 |
2005-04-19 |
3M Innovative Properties Co |
Imidazopiridinas substituìdas por éter
|
EP1543002B1
(en)
*
|
2002-07-23 |
2006-08-30 |
TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság |
Preparation of 1h-imidazo 4,5-c|quinolin-4-amines via1h-imidazo 4,5-c|quinolin-4-phthalimide intermediates
|
KR20050030958A
(ko)
*
|
2002-07-26 |
2005-03-31 |
비오갈 기오기스제르갸르 알티. |
신규한 1H-이미다조[4,5-c]퀴놀린-4-시아노 및1H-이미다조[4,5-c]퀴놀린-4-카르복스아미드 중간체를통한 1H-이미다조[4,5-c]퀴놀린-4-아민의 제조 방법
|
US7427629B2
(en)
|
2002-08-15 |
2008-09-23 |
3M Innovative Properties Company |
Immunostimulatory compositions and methods of stimulating an immune response
|
WO2004028539A2
(en)
*
|
2002-09-26 |
2004-04-08 |
3M Innovative Properties Company |
1h-imidazo dimers
|
WO2004053452A2
(en)
*
|
2002-12-11 |
2004-06-24 |
3M Innovative Properties Company |
Assays relating to toll-like receptor activity
|
AU2003287324A1
(en)
*
|
2002-12-11 |
2004-06-30 |
3M Innovative Properties Company |
Gene expression systems and recombinant cell lines
|
WO2004058759A1
(en)
|
2002-12-20 |
2004-07-15 |
3M Innovative Properties Company |
Aryl / hetaryl substituted imidazoquinolines
|
US7387271B2
(en)
|
2002-12-30 |
2008-06-17 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
EP1592302A4
(en)
*
|
2003-02-13 |
2007-04-25 |
3M Innovative Properties Co |
METHODS AND COMPOSITIONS ASSOCIATED WITH IMMUNE RESPONSE MODIFIER COMPOUNDS AND TOLL-LIKE RECEPTOR 8
|
EP1599726A4
(en)
*
|
2003-02-27 |
2009-07-22 |
3M Innovative Properties Co |
SELECTIVE MODULATION OF TLR-MEDIATED BIOLOGICAL ACTIVITY
|
AU2004218349A1
(en)
|
2003-03-04 |
2004-09-16 |
3M Innovative Properties Company |
Prophylactic treatment of UV-induced epidermal neoplasia
|
US7163947B2
(en)
*
|
2003-03-07 |
2007-01-16 |
3M Innovative Properties Company |
1-Amino 1H-imidazoquinolines
|
CA2517655A1
(en)
*
|
2003-03-07 |
2004-09-23 |
3M Innovative Properties Company |
1-amino 1h-imidazoquinolines
|
JP2006523212A
(ja)
*
|
2003-03-13 |
2006-10-12 |
スリーエム イノベイティブ プロパティズ カンパニー |
皮膚病変の診断方法
|
JP2006520245A
(ja)
*
|
2003-03-13 |
2006-09-07 |
スリーエム イノベイティブ プロパティズ カンパニー |
入れ墨の除去方法
|
EP1603510B1
(en)
*
|
2003-03-13 |
2012-05-09 |
3M Innovative Properties Company |
Methods of improving skin quality
|
US20040192585A1
(en)
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
US20040265351A1
(en)
*
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
EP1615665A4
(en)
*
|
2003-04-10 |
2010-10-06 |
3M Innovative Properties Co |
DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
|
WO2004096144A2
(en)
*
|
2003-04-28 |
2004-11-11 |
3M Innovative Properties Company |
Compositions and methods for induction of opioid receptors
|
US6943255B2
(en)
*
|
2003-06-06 |
2005-09-13 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
US20050032829A1
(en)
*
|
2003-06-06 |
2005-02-10 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
KR20060056354A
(ko)
*
|
2003-07-31 |
2006-05-24 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
트리아진을 포함하는 생체활성 조성물
|
CA2534625A1
(en)
*
|
2003-08-05 |
2005-02-24 |
3M Innovative Properties Company |
Infection prophylaxis using immune response modifier compounds
|
MXPA06001674A
(es)
*
|
2003-08-12 |
2006-05-12 |
3M Innovative Properties Co |
Compuestos que contienen imidazo hidroxilamina-sustituidos.
|
EP2939693A1
(en)
*
|
2003-08-14 |
2015-11-04 |
3M Innovative Properties Company |
Lipid-modified immune response modifiers
|
JP2007504145A
(ja)
*
|
2003-08-25 |
2007-03-01 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫刺激性の組み合わせおよび治療
|
JP2007503268A
(ja)
|
2003-08-25 |
2007-02-22 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答修飾化合物の送達
|
JP5128815B2
(ja)
*
|
2003-08-27 |
2013-01-23 |
スリーエム イノベイティブ プロパティズ カンパニー |
アリールオキシ置換およびアリールアルキレンオキシ置換イミダゾキノリン
|
US20060216333A1
(en)
*
|
2003-09-02 |
2006-09-28 |
Miller Richard L |
Methods related to the treatment of mucosal associated conditions
|
US20050054665A1
(en)
*
|
2003-09-05 |
2005-03-10 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
JP2007505629A
(ja)
*
|
2003-09-17 |
2007-03-15 |
スリーエム イノベイティブ プロパティズ カンパニー |
Tlr遺伝子発現の選択的調節
|
WO2005033049A2
(en)
*
|
2003-10-01 |
2005-04-14 |
Taro Pharmaceuticals U.S.A., Inc. |
METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF
|
KR101494056B1
(ko)
|
2003-10-03 |
2015-02-16 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
피라졸로피리딘 및 그의 유사체
|
EP1673087B1
(en)
*
|
2003-10-03 |
2015-05-13 |
3M Innovative Properties Company |
Alkoxy substituted imidazoquinolines
|
US7544697B2
(en)
*
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
US20090075980A1
(en)
*
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
US20050096259A1
(en)
*
|
2003-10-31 |
2005-05-05 |
3M Innovative Properties Company |
Neutrophil activation by immune response modifier compounds
|
ITMI20032121A1
(it)
*
|
2003-11-04 |
2005-05-05 |
Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm |
Procedimento per la preparazione di imiquimod e suoi intermedi
|
WO2005048933A2
(en)
*
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Oxime substituted imidazo ring compounds
|
CA2545825A1
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo ring compounds
|
EP1686992A4
(en)
*
|
2003-11-25 |
2009-11-04 |
3M Innovative Properties Co |
HYDROXYLAMINE, AND IMIDAZOQUINOLEINS, AND IMIDAZOPYRIDINES AND IMIDAZONAPHTYRIDINE SUBSTITUTED WITH OXIME
|
RU2409576C2
(ru)
|
2003-11-25 |
2011-01-20 |
3М Инновейтив Пропертиз Компани |
Системы, содержащие имидазольное кольцо с заместителями, и способы их получения
|
WO2005055932A2
(en)
*
|
2003-12-02 |
2005-06-23 |
3M Innovative Properties Company |
Therapeutic combinations and methods including irm compounds
|
US20050226878A1
(en)
*
|
2003-12-02 |
2005-10-13 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
AU2004315771A1
(en)
*
|
2003-12-04 |
2005-08-25 |
3M Innovative Properties Company |
Sulfone substituted imidazo ring ethers
|
JP2007517035A
(ja)
*
|
2003-12-29 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
|
EP1699792A1
(en)
|
2003-12-29 |
2006-09-13 |
3M Innovative Properties Company |
Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds
|
CA2551399A1
(en)
*
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
JP2007517055A
(ja)
*
|
2003-12-30 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答の増強
|
US20070167479A1
(en)
*
|
2004-03-15 |
2007-07-19 |
Busch Terri F |
Immune response modifier formulations and methods
|
WO2005094531A2
(en)
*
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
AU2005244260B2
(en)
*
|
2004-04-09 |
2010-08-05 |
3M Innovative Properties Company |
Methods, compositions, and preparations for delivery of immune response modifiers
|
MXPA06012451A
(es)
*
|
2004-04-28 |
2007-01-31 |
3M Innovative Properties Co |
Composiciones y metodos para vacunacion por la mucosa.
|
US20050267145A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Merrill Bryon A |
Treatment for lung cancer
|
WO2005123079A2
(en)
*
|
2004-06-14 |
2005-12-29 |
3M Innovative Properties Company |
Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
WO2005123080A2
(en)
*
|
2004-06-15 |
2005-12-29 |
3M Innovative Properties Company |
Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
JP5128940B2
(ja)
|
2004-06-18 |
2013-01-23 |
スリーエム イノベイティブ プロパティズ カンパニー |
置換イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
|
US20070259881A1
(en)
*
|
2004-06-18 |
2007-11-08 |
Dellaria Joseph F Jr |
Substituted Imidazo Ring Systems and Methods
|
US8026366B2
(en)
*
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
US8541438B2
(en)
*
|
2004-06-18 |
2013-09-24 |
3M Innovative Properties Company |
Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
US7897609B2
(en)
*
|
2004-06-18 |
2011-03-01 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
WO2006065280A2
(en)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
WO2006026470A2
(en)
*
|
2004-08-27 |
2006-03-09 |
3M Innovative Properties Company |
Hiv immunostimulatory compositions
|
WO2006026760A2
(en)
*
|
2004-09-02 |
2006-03-09 |
3M Innovative Properties Company |
1-amino imidazo-containing compounds and methods
|
ES2384390T3
(es)
*
|
2004-09-02 |
2012-07-04 |
3M Innovative Properties Company |
Sistemas cíclicos 1-alcoxi-1H-imidazo y métodos asociados
|
AU2005282523A1
(en)
|
2004-09-02 |
2006-03-16 |
3M Innovative Properties Company |
2-amino 1H imidazo ring systems and methods
|
US20070243215A1
(en)
*
|
2004-10-08 |
2007-10-18 |
Miller Richard L |
Adjuvant for Dna Vaccines
|
WO2006063072A2
(en)
*
|
2004-12-08 |
2006-06-15 |
3M Innovative Properties Company |
Immunomodulatory compositions, combinations and methods
|
US8436176B2
(en)
*
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
EP1831226B1
(en)
*
|
2004-12-30 |
2012-08-08 |
3M Innovative Properties Company |
Chiral tetracyclic compounds inducing interferon biosynthesis
|
AR052447A1
(es)
*
|
2004-12-30 |
2007-03-21 |
3M Innovative Properties Co |
Etansulfonato de 1-(2-metipropil)-1h-imidazo[4,5-c] [1,5] naftiridin-4- amina y metansulfonato de 1-(2- metipropil)-1h-imidazo[4,5 -c] [1,5] naftiridin-4-amina
|
SI1830876T1
(sl)
*
|
2004-12-30 |
2015-08-31 |
Meda Ab |
Uporaba imikvimoda za zdravljenje kožnih metastaz, ki izhajajo iz rakavega tumorja dojke
|
CA2594674C
(en)
|
2004-12-30 |
2016-05-17 |
3M Innovative Properties Company |
Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
|
JP2008530022A
(ja)
*
|
2005-02-04 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫反応調節物質を含む水性ゲル処方物
|
WO2007120121A2
(en)
|
2005-02-09 |
2007-10-25 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
|
CA2597324C
(en)
|
2005-02-09 |
2015-06-30 |
Coley Pharmaceutical Group, Inc. |
Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
|
CA2597446A1
(en)
*
|
2005-02-11 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Substituted imidazoquinolines and imidazonaphthyridines
|
US7968563B2
(en)
|
2005-02-11 |
2011-06-28 |
3M Innovative Properties Company |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
NZ560929A
(en)
|
2005-02-18 |
2009-12-24 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic escherichia coli
|
NZ597685A
(en)
|
2005-02-18 |
2013-12-20 |
Novartis Vaccines & Diagnostic |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
US8846710B2
(en)
*
|
2005-02-23 |
2014-09-30 |
3M Innovative Properties Company |
Method of preferentially inducing the biosynthesis of interferon
|
EP1851218A2
(en)
*
|
2005-02-23 |
2007-11-07 |
3M Innovative Properties Company |
Hydroxyalkyl substituted imidazoquinoline compounds and methods
|
WO2006098852A2
(en)
*
|
2005-02-23 |
2006-09-21 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazoquinolines
|
AU2006216799A1
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazonaphthyridines
|
BRPI0608011A2
(pt)
*
|
2005-03-14 |
2009-11-03 |
Graceway Pharmaceuticals Llc |
uso de uma formulação para o tratamento da queratose actìnica e uso de 2-metil-1-(2-metilpropil)-1h-imidazo[4,5-c][1,5] naftiridin-4-amina
|
EP1863814A1
(en)
|
2005-04-01 |
2007-12-12 |
Coley Pharmaceutical Group, Inc. |
1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
US7943610B2
(en)
|
2005-04-01 |
2011-05-17 |
3M Innovative Properties Company |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
US20080193474A1
(en)
*
|
2005-04-25 |
2008-08-14 |
Griesgraber George W |
Immunostimulatory Compositions
|
ZA200803029B
(en)
*
|
2005-09-09 |
2009-02-25 |
Coley Pharm Group Inc |
Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
|
WO2007030775A2
(en)
*
|
2005-09-09 |
2007-03-15 |
Coley Pharmaceutical Group, Inc. |
Amide and carbamate derivatives of n-{2-[4-amino-2- (ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
|
US7718716B2
(en)
*
|
2005-10-14 |
2010-05-18 |
3M Innovative Properties Company |
Chromonic nanoparticles containing bioactive compounds
|
US7629027B2
(en)
*
|
2005-10-14 |
2009-12-08 |
3M Innovative Properties Company |
Method for making chromonic nanoparticles
|
AU2006310336B2
(en)
|
2005-11-04 |
2011-02-03 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
US20090304742A1
(en)
|
2005-11-04 |
2009-12-10 |
Novartis Vaccines And Diagnostics Srl |
Influenza vaccines with reduced amount of emulsion adjuvant
|
EP1951298A1
(en)
|
2005-11-04 |
2008-08-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Adjuvanted influenza vaccines including cytokine-inducing agents
|
ATE539765T1
(de)
|
2005-11-04 |
2012-01-15 |
Novartis Vaccines & Diagnostic |
Grippeimpfstoffe mit kombinationen aus teilchenförmigen adjuvantien und immunverstärkern
|
CA2628131C
(en)
*
|
2005-11-04 |
2012-03-20 |
Coley Pharmaceutical Group, Inc. |
Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
|
US20070128291A1
(en)
*
|
2005-12-07 |
2007-06-07 |
Tokie Jeffrey H |
Method and Apparatus for Forming Chromonic Nanoparticles
|
US7807661B2
(en)
*
|
2005-12-08 |
2010-10-05 |
3M Innovative Properties Company |
Silver ion releasing articles and methods of manufacture
|
US7323568B2
(en)
*
|
2005-12-12 |
2008-01-29 |
Chemagis Ltd. |
Process for preparing Imiquimod
|
KR20080089663A
(ko)
|
2006-01-27 |
2008-10-07 |
노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게 |
적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
|
EP1988896A4
(en)
|
2006-02-22 |
2011-07-27 |
3M Innovative Properties Co |
CONJUGATES TO MODIFY IMMUNE REACTIONS
|
US8329721B2
(en)
*
|
2006-03-15 |
2012-12-11 |
3M Innovative Properties Company |
Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
|
EP2382987A1
(en)
|
2006-03-24 |
2011-11-02 |
Novartis Vaccines and Diagnostics GmbH |
Storage of influenza vaccines without refrigeration
|
EP2019686B1
(en)
|
2006-03-31 |
2012-07-11 |
Novartis AG |
Combined mucosal and parenteral immunization against hiv
|
WO2008020335A2
(en)
|
2006-06-09 |
2008-02-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
WO2008008432A2
(en)
*
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
AU2007285484B2
(en)
|
2006-08-16 |
2013-05-02 |
Novartis Ag |
Immunogens from uropathogenic Escherichia coli
|
WO2008023333A2
(en)
*
|
2006-08-22 |
2008-02-28 |
Ranbaxy Laboratories Limited |
Process for the preparation of 4-(isobutylamino)-3-amino-quinoline
|
US8178539B2
(en)
*
|
2006-09-06 |
2012-05-15 |
3M Innovative Properties Company |
Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
|
CA2663196A1
(en)
|
2006-09-11 |
2008-03-20 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
US20080103310A1
(en)
*
|
2006-10-16 |
2008-05-01 |
Janos Hajko |
Preparation of 1H-imidazo[4,5-c]quinolin-4-amines via 1H-imidazo[4, 5-c]quinolin-4-phtalimide intermediates
|
WO2008068631A2
(en)
|
2006-12-06 |
2008-06-12 |
Novartis Ag |
Vaccines including antigen from four strains of influenza virus
|
US20080149123A1
(en)
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
US7943771B2
(en)
*
|
2007-01-24 |
2011-05-17 |
Chemagis Ltd. |
Imiquimod production process
|
US7659398B2
(en)
*
|
2007-02-14 |
2010-02-09 |
Chemagis Ltd. |
Imiquimod production process
|
EP2125742A2
(en)
*
|
2007-03-08 |
2009-12-02 |
Chemagis Ltd. |
(1r,1'r)-atracurium salts separation process
|
US20100087650A1
(en)
*
|
2007-03-26 |
2010-04-08 |
Chemagis Ltd. |
(1r,1'r)-atracurium salts separation process
|
BRPI0809893A2
(pt)
*
|
2007-05-01 |
2014-09-30 |
Chemagis Ltd |
Processo para prepar um sal de (1r-cis) - [(3,4 - dimetoxifenil) metil] - 1, 2,3,4 - tetraidro - 6,7 - dimetoxi - 2 - metil - 2 - carboxietil - isoquinolínio"
|
AU2008273724B2
(en)
*
|
2007-05-01 |
2013-05-23 |
Chemagis Ltd. |
Process for Producing Cisatracurium and Associated Intermediates
|
CA2687157A1
(en)
*
|
2007-06-18 |
2008-12-24 |
Chemagis Ltd. |
(1r,1'r)-atracurium salts separation process
|
EP2009002A1
(en)
*
|
2007-06-21 |
2008-12-31 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
|
JP2010531348A
(ja)
|
2007-06-27 |
2010-09-24 |
ノバルティス アーゲー |
添加剤の少ないインフルエンザワクチン
|
EP2176227A1
(en)
*
|
2007-07-09 |
2010-04-21 |
Chemagis Ltd. |
Process for producing cisatracurium and associated intermediates
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
AU2008320380A1
(en)
*
|
2007-10-29 |
2009-05-07 |
Chemagis Ltd. |
Novel R,R'-atracurium salts
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
CA2718430A1
(en)
|
2008-03-18 |
2009-09-24 |
Novartis Ag |
Improvements in preparation of influenza virus vaccine antigens
|
US20110185796A1
(en)
*
|
2008-05-01 |
2011-08-04 |
Chemagis Ltd. |
Cisatracurium derivatives, preparation and uses thereof
|
RU2011140508A
(ru)
|
2009-03-06 |
2013-04-20 |
Новартис Аг |
Антигены хламидии
|
SI2510947T1
(sl)
|
2009-04-14 |
2016-05-31 |
Glaxosmithkline Biologicals S.A. |
Sestavki za imunizacijo proti Staphylococcus aureus
|
USH2283H1
(en)
|
2009-04-27 |
2013-09-03 |
Novartis Ag |
Vaccines for protecting against influenza
|
AU2010269961A1
(en)
|
2009-07-07 |
2012-02-02 |
Novartis Ag |
Conserved Escherichia coli immunogens
|
ES2918381T3
(es)
|
2009-07-15 |
2022-07-15 |
Glaxosmithkline Biologicals Sa |
Composiciones de proteína F de VRS y métodos para producir las mismas
|
SI2464658T1
(sl)
|
2009-07-16 |
2015-02-27 |
Novartis Ag |
Detoksificirani imunogeni escherichie coli
|
US20110033515A1
(en)
*
|
2009-08-04 |
2011-02-10 |
Rst Implanted Cell Technology |
Tissue contacting material
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
E.coliキャリアタンパク質に結合体化した多糖免疫原
|
CA2801149A1
(en)
|
2010-06-01 |
2011-12-08 |
Novartis Ag |
Concentration of vaccine antigens without lyophilization
|
JP5976639B2
(ja)
|
2010-06-01 |
2016-08-23 |
ノバルティス アーゲー |
インフルエンザワクチン抗原の濃縮および凍結乾燥
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
CA2808624C
(en)
|
2010-08-17 |
2019-05-14 |
3M Innovative Properties Company |
Lipidated immune response modifier compound compositions, formulations, and methods
|
AU2011290471B2
(en)
|
2010-08-20 |
2015-08-20 |
Novartis Ag |
Soluble needle arrays for delivery of influenza vaccines
|
LT2667892T
(lt)
|
2011-01-26 |
2019-05-10 |
Glaxosmithkline Biologicals Sa |
Rsv imunizacijos režimas
|
SI2707385T1
(en)
|
2011-05-13 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Pregnant RSV F antigens
|
EP3366311B1
(en)
|
2011-06-03 |
2020-02-26 |
3M Innovative Properties Co. |
Hydrazino-1h-imidazoquinolin-4-amines and conjugates made therefrom
|
WO2012167088A1
(en)
|
2011-06-03 |
2012-12-06 |
3M Innovative Properties Company |
Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
|
JP6088507B2
(ja)
|
2011-07-08 |
2017-03-01 |
ノバルティス アーゲー |
チロシンライゲーションの方法
|
US20130023736A1
(en)
|
2011-07-21 |
2013-01-24 |
Stanley Dale Harpstead |
Systems for drug delivery and monitoring
|
CN104080479B
(zh)
|
2011-11-07 |
2019-11-05 |
葛兰素史密丝克莱恩生物有限公司 |
包括spr0096和spr2021抗原的运载体分子
|
WO2013108272A2
(en)
|
2012-01-20 |
2013-07-25 |
International Centre For Genetic Engineering And Biotechnology |
Blood stage malaria vaccine
|
CA2871711A1
(en)
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
US20160101187A1
(en)
|
2012-10-02 |
2016-04-14 |
Novartis Ag |
Nonlinear saccharide conjugates
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
CN106103469B
(zh)
|
2014-03-26 |
2020-11-27 |
葛兰素史密丝克莱恩生物有限公司 |
突变型葡萄球菌抗原
|
CA3086439A1
(en)
|
2017-12-20 |
2019-06-27 |
3M Innovative Properties Company |
Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
|
FR3113287B1
(fr)
|
2020-08-07 |
2023-06-23 |
Phv Pharma |
Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
|